Skip to main content

Core value dossiers for medical technologies

Essential tool to support market access and marketing efforts through the lifecycle of the product

Learn more

White Paper: Market access for medical devices in Europe: England, France, Germany, Italy and Spain

Get insights from MTRC White Papers to advance your understanding of European market access for medical devices

Request free of charge
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Publication Digest: Requirements for patient-reported outcomes and data analytics in health technology assessment in England, France and Germany, and the need for methods harmonization across European markets: a qualitative interview study

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. 

In a recent publication, DiModica et al. explored the role of patient-reported outcomes (PRO) in HTA decision-making across England, France, and Germany. Through 12 expert interviews supported by a targeted literature review, the authors showed that PRO guidance differs substantially between countries, creating uncertainty for evidence generation and submission planning. 

The study found a stronger perceived influence of PRO data in Germany and a more context-dependent impact in England and France. The authors also highlighted misalignment between national HTA expectations and emerging Joint Clinical Assessment guidance as an additional barrier to harmonized evidence use across Europe.

Access the full-text article here.